CerRx, Inc. — Form D/A
CerRx, Inc. of LUBBOCK, TX, a company, filed a Form D amendment with the SEC on 2013-02-04. The offering totals $4.5M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-02-04
- Form: D/A
- Accession: 0001538929-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $4.5M
- Amount sold: $2.1M
- Remaining: $2.4M
- Minimum investment: $56K
- Investors: 6
- Date of first sale: 2011-12-28
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-171480
Issuer
- Name: CerRx, Inc.
- CIK: 0001538929
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 9801 REESE BLVD, LUBBOCK, TX, 79416
- Phone: 806-780-6068
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Richard Love | Director | Scottsdale, AZ |
| Barry Maurer, M.D., Ph.D. | Director | Lubbock, TX |
| C. Patrick Reynolds, M.D., Ph.D. | Director | Lubbock, TX |
| William Patrick Simpson | Director | Lubbock, TX |
| Richard Love | Executive Officer | Scottsdale, AZ |
| William Patrick Simpson | Executive Officer | Lubbock, TX |
Other filings by this issuer (3)
More